alexa Nam H Dang | University of Florida
ISSN: 2157-7013

Journal of Cell Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Nam H Dang

Nam H Dang Nam H Dang
Professor and Deputy Division Chief
Division of Hematology/Oncology
University of Florida
USA
Biography

Nam H Dang, MD, PhD is Professor of Medicine, Deputy Chief of the Division of Hematology/Oncology, Department of Medicine, University of Florida. He is also Director of the University of Florida Shands Cancer Center Clinical Trials Office. He completed his BA (magna cum laude) in Biochemical Sciences from Harvard University (1985). He received his PhD in Immunology from Harvard University (1991) and his MD (magna cum laude) from Harvard Medical School (1992). He performed his internship and residency in Internal Medicine at Massachusetts, General Hospital, and his fellowship in Medical Oncology at Dana-Farber Cancer Institute. He was a recipient of the Friends Fellowship of Dana-Farber Cancer Institute, the MD Anderson Cancer Center Physician-Scientist Award, the Howard Hughes Medical Institute Postdoctoral Research Fellowship for Physicians, and the American College of Rheumatology Outstanding Medical Student Achievement Award.  He has published 90 peer-reviewed articles, has authored 9 book chapters, and was the Editor-in-Chief of a review book on T-cell lymphomas. He has served as a reviewer for multiple scientific journals.  His pioneering work on the surface antigen CD26/Dipeptidyl peptidase IV has resulted in the development of a novel anti-CD26 antibody which is currently in clinical development.

Research Interest

Cancer Diagnosis and Treatment, Clinical Trials, Lymphoma and Leukemia CD26/Dipeptidyl Peptidase IV.

Certificate
Certificate

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemis[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords